Patent · US Active

Lipid encapsulated interfering RNA

US7982027B2 · kind B2 · utility

115Cited by
34References
63Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 27, 2006
Grant dateJul 19, 2011
Priority date
Expiry dateJun 27, 2026

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P31/20
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides compositions and methods for silencing gene expression by delivering nucleic acid-lipid particles comprising a siRNA molecule to a cell.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.